课题基金 / 基金详情

Basic Studies on Prediction of Adverse Reactins to Pyrimidine Anti-Cancer Drugs-Analyses on Pyrimidine Metaboism Disonders-

Basic Studies on Prediction of Adverse Reactins to Pyrimidine Anti-Cancer Drugs-Analyses on Pyrimidine Metaboism Disonders-
嘧啶类抗癌药物不良反应预测的基础研究-嘧啶代谢障碍分析-
批准号:
11470173
负责人:
SUMI Satoshi
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Analysis on dihydropyrimidinase mRNAAnalysis on the dihydropyrimidinase genomic DNA needs complicated procedures because it has 10 exons. We could separated mRNA from peripheral blood, using ISOGEN.After subcloned, we sequenced cDNA.We identified the reported mutations In the patient with dihydropyrimidinuria, suggesting that this method is clinically useful.2. Analysis on dihydropyrimidine dehydrogenase in two patient with a severe fluorouracil toxicityWe analysed the dihydropyrimidine dehydrogenase gene in two patient with a severe fluorouracil toxicity. and identified novel mutations. The patient 1 had a 1003G→T) mutation and a 1156G→Tmutation. We diagnosed the patient as having DPD deflciency, and supeculated that these mutations were associated with a severe fluorouracil toxicity.The patient 2 had a 1626A→G mutation, but we could not clarify the relationship between this mutation and a severe fluorouracil toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金